Please assess the completion status of the following clinical trial:

Trial Title: Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Turner Syndrome~* Well documented growth rate during the previous year~* Height below the 50th percentile for the age in Dutch children~* Normal thyroid function~Exclusion Criteria:~* Any endocrine or metabolic disorder~* Growth failure due to disorders of genitourinary, cardio-pulmonary, gastro-intestinal and nervous systems, nutritional/vitamins deficiencies and chondrodysplasias~* Patients with hydrocephalus

- Gender: FEMALE
- Minimum Age: 2 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- Low dose (Type: EXPERIMENTAL): None
- Medium dose (Type: EXPERIMENTAL): None
- High dose (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).